Quick Answer
Arcus Biosciences, Inc. reported Net Income of -$353.00 million for fiscal year 2025.
Arcus Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$353.00M | -24.7% |
| 2024 | -$283.00M | +7.8% |
| 2023 | -$307.00M | -15.0% |
| 2022 | -$267.00M | -603.8% |
| 2021 | $53.00M | +143.1% |
| 2020 | -$123.00M | -45.2% |
| 2019 | -$84.71M | -70.8% |
| 2018 | -$49.59M | +6.6% |
| 2017 | -$53.08M | -195.4% |
| 2016 | -$17.97M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$135.00M | -46.7% | — |
| June 30, 2025 | $0.00 | +100.0% | +100.0% |
| March 31, 2025 | -$112.00M | -2700.0% | -21.7% |
| September 30, 2024 | -$92.00M | -29.6% | +1.1% |
| June 30, 2024 | -$93.00M | -24.0% | -2225.0% |
| March 31, 2024 | -$4.00M | +95.0% | +94.4% |
| September 30, 2023 | -$71.00M | -9.2% | +5.3% |
| June 30, 2023 | -$75.00M | -11.9% | +6.2% |
- Arcus Biosciences, Inc. showed a decrease of -24.7% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Arcus Biosciences, Inc.’s net income has declined by 1864.4% (from -$17.97 million to -$353.00 million).
- The most recent figure is from Arcus Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: